Verastem Inc (VSTM)
6.56
-0.16
(-2.38%)
USD |
NASDAQ |
Jan 07, 16:00
6.67
+0.11
(+1.68%)
After-Hours: 16:33
Verastem Research and Development Expense (Annual): 61.36M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| ACADIA Pharmaceuticals Inc | 351.62M |
| CytomX Therapeutics Inc | 77.68M |
| Applied Therapeutics Inc | 53.90M |
| Poseida Therapeutics Inc | 156.77M |
| Reviva Pharmaceuticals Holdings Inc | 31.42M |